Chemoinformaics analysis of Mangiferin-60 -O-Gallate
| Molecular Weight | 574.447 | nRot | 4 |
| Heavy Atom Molecular Weight | 552.271 | nRig | 30 |
| Exact Molecular Weight | 574.096 | nRing | 5 |
| Solubility: LogS | -4.111 | nHRing | 2 |
| Solubility: LogP | 0.884 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 3 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 20 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 22 |
| nHA | 15 | APOL | 70.1194 |
| nHD | 10 | BPOL | 29.0146 |
| QED | 0.089 |
| Synth | 4.363 |
| Natural Product Likeliness | 1.57 |
| NR-PPAR-gamma | 0.942 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.055 |
| HIA | 0.983 |
| CACO-2 | -6.503 |
| MDCK | 0.00000424 |
| BBB | 0.008 |
| PPB | 0.866266 |
| VDSS | 0.664 |
| FU | 0.239471 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.032 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.037 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.101 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.004 |
| CL | 5.924 |
| T12 | 0.895 |
| hERG | 0.083 |
| Ames | 0.459 |
| ROA | 0.005 |
| SkinSen | 0.943 |
| Carcinogencity | 0.016 |
| EI | 0.852 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.818 |
| Antiviral | Yes |
| Prediction | 0.52244 |